Please assess the completion status of the following clinical trial:

Trial Title: Lidocaine Infusion in Radical Cystectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 45-75 yr ASA class I,II, and III Elective radical cystectomy~Exclusion Criteria:~* Allergy to the study medication, pre-existing chronic pain at any site requiring treatment, Psychiatric disease, hepatic or renal impairment, seizure disorder requiring medication within the previous 2 years

- Gender: ALL
- Minimum Age: 45 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Lidocaine (Type: EXPERIMENTAL): IV Lidocaine infusion
- Control (Type: PLACEBO_COMPARATOR): IV normal saline infusion

Based on this trial design, predict the completion outcome and termination type (if applicable).